Literature DB >> 15804954

Autistic disorder and viral infections.

Jane E Libbey1, Thayne L Sweeten, William M McMahon, Robert S Fujinami.   

Abstract

Autistic disorder (autism) is a behaviorally defined developmental disorder with a wide range of behaviors. Although the etiology of autism is unknown, data suggest that autism results from multiple etiologies with both genetic and environmental contributions, which may explain the spectrum of behaviors seen in this disorder. One proposed etiology for autism is viral infection very early in development. The mechanism, by which viral infection may lead to autism, be it through direct infection of the central nervous system (CNS), through infection elsewhere in the body acting as a trigger for disease in the CNS, through alteration of the immune response of the mother or offspring, or through a combination of these, is not yet known. Animal models in which early viral infection results in behavioral changes later in life include the influenza virus model in pregnant mice and the Borna disease virus model in newborn Lewis rats. Many studies over the years have presented evidence both for and against the association of autism with various viral infections. The best association to date has been made between congenital rubella and autism; however, members of the herpes virus family may also have a role in autism. Recently, controversy has arisen as to the involvement of measles virus and/or the measles, mumps, rubella (MMR) vaccine in the development of autism. Biological assays lend support to the association between measles virus or MMR and autism whereas epidemiologic studies show no association between MMR and autism. Further research is needed to clarify both the mechanisms whereby viral infection early in development may lead to autism and the possible involvement of the MMR vaccine in the development of autism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15804954     DOI: 10.1080/13550280590900553

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  107 in total

Review 1.  The epidemiology of autism: a review.

Authors:  E Fombonne
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

Review 2.  Pentoxifylline: brief review and rationale for its possible use in the treatment of autism.

Authors:  S Gupta; B Rimland; P D Shilling
Journal:  J Child Neurol       Date:  1996-11       Impact factor: 1.987

3.  Neurologic disorders after measles-mumps-rubella vaccination.

Authors:  Annamari Mäkelä; J Pekka Nuorti; Heikki Peltola
Journal:  Pediatrics       Date:  2002-11       Impact factor: 7.124

4.  Brief report: autistic disorder in three children with cytomegalovirus infection.

Authors:  Thayne L Sweeten; David J Posey; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2004-10

Review 5.  The amygdala and related structures in the pathophysiology of autism.

Authors:  Thayne L Sweeten; David J Posey; Anantha Shekhar; Christopher J McDougle
Journal:  Pharmacol Biochem Behav       Date:  2002-03       Impact factor: 3.533

6.  The changing prevalence of autism in California.

Authors:  Lisa A Croen; Judith K Grether; Jenny Hoogstrate; Steve Selvin
Journal:  J Autism Dev Disord       Date:  2002-06

7.  Acquired reversible autistic syndrome in acute encephalopathic illness in children.

Authors:  G R DeLong; S C Bean; F R Brown
Journal:  Arch Neurol       Date:  1981-03

8.  Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction.

Authors:  P Sola; E Merelli; R Marasca; M Poggi; M Luppi; M Montorsi; G Torelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

9.  High nitric oxide production in autistic disorder: a possible role for interferon-gamma.

Authors:  Thayne L Sweeten; David J Posey; Sudha Shankar; Christopher J McDougle
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

10.  Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system.

Authors:  D M Araujo; P A Lapchak; B Collier; R Quirion
Journal:  Brain Res       Date:  1989-10-02       Impact factor: 3.252

View more
  70 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

2.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

3.  Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.

Authors:  D Ehninger; Y Sano; P J de Vries; K Dies; D Franz; D H Geschwind; M Kaur; Y-S Lee; W Li; J K Lowe; J A Nakagawa; M Sahin; K Smith; V Whittemore; A J Silva
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

Review 4.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

5.  Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.

Authors:  Paul Ashwood; Joseph Schauer; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2009-02-10       Impact factor: 3.478

6.  Association of autism with polyomavirus infection in postmortem brains.

Authors:  Carla Lintas; Laura Altieri; Federica Lombardi; Roberto Sacco; Antonio M Persico
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

7.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

8.  Up-Regulation of Oligodendrocyte Lineage Markers in the Cerebellum of Autistic Patients: Evidence from Network Analysis of Gene Expression.

Authors:  Fares Zeidán-Chuliá; Ben-Hur Neves de Oliveira; Manuel F Casanova; Emily L Casanova; Mami Noda; Alla B Salmina; Alexei Verkhratsky
Journal:  Mol Neurobiol       Date:  2015-07-21       Impact factor: 5.590

9.  Prevalence of Congenital Cytomegalovirus Infection Assessed Through Viral Genome Detection in Dried Blood Spots in Children with Autism Spectrum Disorders.

Authors:  Ivan Gentile; Emanuela Zappulo; Maria Pia Riccio; Sandro Binda; Laura Bubba; Laura Pellegrinelli; Domenico Scognamiglio; Francesca Operto; Lucia Margari; Guglielmo Borgia; Carmela Bravaccio
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

10.  Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

Authors:  Linnéa Asp; Maria Holtze; Susan B Powell; Håkan Karlsson; Sophie Erhardt
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-17       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.